Market Place
Sourcing Support
EMA Grants SN Bio`s SNB-101 Orphan Drug Status For SCLC
31 May 2024 //
PR NEWSWIRE
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
09 May 2024 //
PR NEWSWIRE
SN Bio received FDA Orphan Drug Designation for Nano Anti-Cancer Drug `SNB-101`
29 Feb 2024 //
PR NEWSWIRE
SN BioScience and Boryung Announce the Agreement on Generic Version of Abraxane
26 Jan 2023 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.